Biocept, Inc. - Personalized Medicine From a Liquid Biopsy Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Biocept, Inc. is a biotechnology research company based in San Diego that develops and performs clinical laboratory tests for cancer that has spread to the central nervous system. Its CNSide assay analyzes tumor cells and circulating tumor DNA in cerebrospinal fluid to generate quantitative results that help assess a patient’s response to treatment. Conducted in a CLIA-certified and CAP-accredited laboratory, the test aims to determine whether there is tumor in the CSF, identify potential treatment targets, and track treatment response over time. In addition to CNS diagnostics, Biocept offers RT-PCR based COVID-19 testing to support public health efforts. A notable recent development is a 2023 collaboration in which Plus Therapeutics expanded its supply agreement with Biocept, obtaining an option to exclusively license CNSide for use in patients receiving CNS radiotherapy.